Abstract
In the course of our screening program for vasoactive compounds using co-culture assay of endothelial cells and fibroblast cells, potent activity was detected in the cultured broth of Incrucipulum sp. SANK 10414. Two active compounds, F-36316 A and B, and a non-active homolog, F-36316 C, were isolated from the broth. The structures of F-36316 A, B and C were elucidated by physicochemical data and spectral analyses, and found to be new 3-acylated tetronic acid homologs. F-36316 A and B induced morphological changes of endothelial cells different from vascular endothelial growth factor (VEGF) or vestaines in the assay with EC50 values of 1.8 and 11.7 μM, respectively. Furthermore, F-36316 A and B suppressed VEGF-induced vascular permeability induction in mice.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bates, D. O. Vascular endothelial growth factors and vascular permeability. Cardiovasc. Res. 87, 262–271 (2010).
Aiello, L. P. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480–1487 (1994).
Mathews, M. K., Merges, C., McLeod, D. S. & Lutty, G. A. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 38, 2729–2741 (1997).
Weinberg, D. G. et al. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg. Focus 30, E20 (2011).
Jain, R. K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58–62 (2005).
Ishimoto, Y. et al. A novel natural product-derived compound, vestaine A1, exerts both pro-angiogenic and anti-permeability activity via a different pathway from VEGF. Cell Physiol. Biochem. 39, 1905–1918 (2016).
Hirota-Takahata, Y. et al. Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697. J. Antibiot. 70, 179–186 (2017).
Yamaguchi, T., Saito, K., Tsujimoto, T. & Yuki, H. Nmr spectroscopic studies on the tautomerism in tenuazonic acid analogs. J. Heterocyclic Chem. 13, 533–537 (1976).
Roggo, E. B. et al. 3-Alkanoyl-5-hydroxymethyl tetronic acid homologues and resistomycin: new inhibitors of HIV-1 protease I. Fermentation, isolation and biological activity. J. Antibiot. 47, 136–142 (1994).
Roggo, E. B., Hug, P., Moss, S., Raschdorf, F. & Peter, H. H. 3-Alkanoyl-5-hydroxymethyl tetronic acid homologues: new inhibitors of HIV-1 protease II. Structure determination. J. Antibiot. 47, 143–147 (1994).
Shoji, J. et al. Isolation and characterization of agglomerins A, B, C and D. J. Antibiot. 42, 1729–1733 (1989).
Terui, Y. et al. Structures of agglomerins. J. Antibiot. 43, 1245–1253 (1990).
Angawi, R. E. et al. Lowdenic acid: a new antifungal polyketide-derived metabolite from a new fungicolous Verticillium sp. J. Nat. Prod. 66, 1259–1262 (2003).
Hamaguchi, T., Sudo, T. & Osada, H. RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1 phase. FEBS Lett. 372, 54–58 (1995).
Sodeoka, M. et al. Asymmetric synthesis of a 3-acyltetronic acid derivative, RK-682, and formation of its calcium salt during silica gel column chromatography. Chem. Pharm. Bull. 49, 206–212 (2001).
Goel, S. et al. Effects of vascular-endothelial protein tyrosine phosphate inhibition on breast cancer vasculature and metastatic progression. J. Natl Cancer Inst. 105, 1188–1201 (2013).
Shen, J. et al. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J. Clin. Invest. 124, 4564–4576 (2014).
An, S., Zheng, Y. & Bleu, T. Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. J. Biol. Chem. 275, 288–296 (2000).
Kimura, T. et al. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem. J. 348, 71–76 (2000).
Sammani, S. et al. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. Am. J. Respir. Cell Mol. Biol. 43, 394–402 (2010).
Sodeoka, M. et al. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dial-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition. J. Med. Chem. 44, 3216–3222 (2001).
Usui, T. et al. Design and synthesis of a dimeric derivative of RK-682 with increased inhibitory activity against VHR, a dual-specificity ERK phosphatase: implications for the molecular mechanism of the inhibition. Chem. Biol. 8, 1209–1220 (2001).
Hirai, G. & Sodeoka, M. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings. Acc. Chem. Res. 48, 1464–1473 (2015).
Hosoya, T. et al. Molecular phylogenetic studies of Lachnum and its allies based on the Japanese material. Mycosciense 51, 170–181 (2010).
Acknowledgements
We are grateful to Dr Toshio Takatsu, Dr Yasunori Muramatsu and Mr Satoru Ohsuki for useful advice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on The Journal of Antibiotics website
Supplementary information
Rights and permissions
About this article
Cite this article
Hirota-Takahata, Y., Ishimoto, Y., Kurosawa, E. et al. F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414. J Antibiot 70, 981–986 (2017). https://doi.org/10.1038/ja.2017.84
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2017.84
